The 5 linked references in paper E. Amelina L., S. Krasovskiy A., M. Usacheva V., N. Krylova A., Е. Амелина Л., С. Красовский А., М. Усачева В., Н. Крылова А. (2017) “Патогенетическое лечение муковисцидоза: первый клинический случай в России // Pathogenic treatment of cystic fibrosis: the first clinical case in Russia” / spz:neicon:pulmonology:y:2017:i:2:p:298-301

  1. Tsui L.C., Buchwald M. Biochemical and molecular genetics of cystic fibrosis. Adv. Hum. Genet.1991; 20: 153–266. DOI: 10.1007/978-1-4684-5958-6_4.
  2. Riordan J.R., Rommens J.M., Kerem B.T. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 1989; 245 (4922): 1066–1073. DOI: 10.1126/science.2475911.
  3. Griesenbach U., Geddes D.M., Alton E.W. Gene therapy for cystic fibrosis: an example for lung gene therapy.Gene Ther. 2004; 11 (Suppl. 1): S43–50. DOI: 10.1038/sj.gt. 3302368.
  4. Bell S.C., De Boeck K., Amaral M.D. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Pharmacol. Ther.2015; 145: 19–34. DOI: 10.1016/ j.pharmthera.2014.06.005.
  5. Solomon G.M., Marshall S.G., Ramsey B. W. et al. Breakthrough Therapies: Cystic. Fibrosis (CF) Potentiators and Correctors. Pediatr. Pulmonol.2015; 50 (Suppl. 40): S3–S13. DOI: 10.1002/ppul.23240. Поступила 06.02.17